{"id":15446,"date":"2023-08-03T13:18:00","date_gmt":"2023-08-03T05:18:00","guid":{"rendered":"https:\/\/flcube.com\/?p=15446"},"modified":"2024-12-03T22:05:05","modified_gmt":"2024-12-03T14:05:05","slug":"national-health-commissions-anti-corruption-drive-impacts-chinas-pharmaceutical-sector","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=15446","title":{"rendered":"National Health Commission&#8217;s Anti-Corruption Drive Impacts China&#8217;s Pharmaceutical Sector"},"content":{"rendered":"\n<p>An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July has quickly begun to impact the healthcare industry. Unlike previous efforts led by local authorities, this campaign is being driven by central authorities, with the Commission for Discipline Inspection of the Central Committee of the CPC holding a mobilization meeting in conjunction with the launch. Provinces and cities, including Zhejiang and Guangdong, have introduced related policies to correct unhealthy practices in pharmaceutical procurement and sales, as well as medical services.<\/p>\n\n\n\n<p><strong>Unprecedented Impact on the Pharmaceutical Industry<\/strong><br>The crackdown has been unprecedented, causing a significant shock to the pharmaceutical industry. Medical institutions have requested personnel to self-check and correct any unreasonable remunerations, proactively returning monies that could be construed as bribes, including sales rebates and lecture fees. This has led to share price declines for several China-listed pharmaceutical companies, with industry leader Hengrui Pharmaceuticals (<a href=\"https:\/\/www.google.com\/finance\/quote\/600276:SHA\">SHA: 600276<\/a>) experiencing a near-daily limit drop of 9.18% on August 2, 2023. Amid social media rumors, Hengrui denied that its offices had been raided but has reportedly disbanded multiple group chats related to &#8220;lecture fees&#8221; and recalled pharmaceutical representatives for internal training.<\/p>\n\n\n\n<p><strong>Investigations and Industry Response<\/strong><br>As of 2023, at least 155 hospital presidents and secretaries have been investigated nationwide, more than double the number for the entire previous year, according to https:\/\/www.cnr.cn\/. In July, Zhou Wei, chairman of Winning Health Technology Group Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/300253:SHE\">SHE: 300253<\/a>), a medical information company, and Fan Zhihe, chairman of Shanghai Serum Bio-Technology Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/688163:SHA\">SHA: 688163<\/a>), an antivenom specialist, were investigated for suspected bribery and duty crimes, respectively.<\/p>\n\n\n\n<p><strong>Regulatory Warnings and Industry Costs<\/strong><br>The Shenzhen Stock Exchange, in February, released a \u201cReport on the Supervision of Commercial Bribery Related Issues in Shenzhen Pharmaceutical Companies,\u201d warning against corrupt practices in the pharmaceutical industry. The report highlighted that the &#8220;cost of sales&#8221; reported by the pharmaceutical industry in Shenzhen is significantly higher than the average for other industries, with 18 listed companies having sales expenses accounting for over 50% of operating revenue. The report suggests that some companies&#8217; sales expenses are almost entirely promotional, indicating a relatively high possibility of commercial bribery risk.<a href=\"https:\/\/flcube.com\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[61,4],"tags":[2586,67,14,98,2443,852,2442],"class_list":["post-15446","post","type-post","status-publish","format-standard","hentry","category-legal-ip","category-policy-regulatory","tag-hengrui-pharmaceuticals","tag-nhsa-prev-smia","tag-nmpa","tag-samr","tag-serum-bio-technology","tag-sha-600276","tag-winning-health-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>National Health Commission&#039;s Anti-Corruption Drive Impacts China&#039;s Pharmaceutical Sector - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July has quickly begun to impact the healthcare industry. Unlike previous efforts led by local authorities, this campaign is being driven by central authorities, with the Commission for Discipline Inspection of the Central Committee of the CPC holding a mobilization meeting in conjunction with the launch. Provinces and cities, including Zhejiang and Guangdong, have introduced related policies to correct unhealthy practices in pharmaceutical procurement and sales, as well as medical services.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=15446\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"National Health Commission&#039;s Anti-Corruption Drive Impacts China&#039;s Pharmaceutical Sector\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=15446\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T05:18:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-03T14:05:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15446#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15446\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"National Health Commission&#8217;s Anti-Corruption Drive Impacts China&#8217;s Pharmaceutical Sector\",\"datePublished\":\"2023-08-03T05:18:00+00:00\",\"dateModified\":\"2024-12-03T14:05:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15446\"},\"wordCount\":365,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Hengrui Pharmaceuticals\",\"NHSA (prev. SMIA)\",\"NMPA\",\"SAMR\",\"Serum Bio-Technology\",\"SHA: 600276\",\"Winning Health Technology\"],\"articleSection\":[\"Legal \\\/ IP\",\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=15446#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15446\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=15446\",\"name\":\"National Health Commission's Anti-Corruption Drive Impacts China's Pharmaceutical Sector - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-08-03T05:18:00+00:00\",\"dateModified\":\"2024-12-03T14:05:05+00:00\",\"description\":\"An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July has quickly begun to impact the healthcare industry. Unlike previous efforts led by local authorities, this campaign is being driven by central authorities, with the Commission for Discipline Inspection of the Central Committee of the CPC holding a mobilization meeting in conjunction with the launch. Provinces and cities, including Zhejiang and Guangdong, have introduced related policies to correct unhealthy practices in pharmaceutical procurement and sales, as well as medical services.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15446#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=15446\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15446#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"National Health Commission&#8217;s Anti-Corruption Drive Impacts China&#8217;s Pharmaceutical Sector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"National Health Commission's Anti-Corruption Drive Impacts China's Pharmaceutical Sector - Insight, China&#039;s Pharmaceutical Industry","description":"An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July has quickly begun to impact the healthcare industry. Unlike previous efforts led by local authorities, this campaign is being driven by central authorities, with the Commission for Discipline Inspection of the Central Committee of the CPC holding a mobilization meeting in conjunction with the launch. Provinces and cities, including Zhejiang and Guangdong, have introduced related policies to correct unhealthy practices in pharmaceutical procurement and sales, as well as medical services.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=15446","og_locale":"en_US","og_type":"article","og_title":"National Health Commission's Anti-Corruption Drive Impacts China's Pharmaceutical Sector","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=15446","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-08-03T05:18:00+00:00","article_modified_time":"2024-12-03T14:05:05+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=15446#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=15446"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"National Health Commission&#8217;s Anti-Corruption Drive Impacts China&#8217;s Pharmaceutical Sector","datePublished":"2023-08-03T05:18:00+00:00","dateModified":"2024-12-03T14:05:05+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=15446"},"wordCount":365,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Hengrui Pharmaceuticals","NHSA (prev. SMIA)","NMPA","SAMR","Serum Bio-Technology","SHA: 600276","Winning Health Technology"],"articleSection":["Legal \/ IP","Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=15446#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=15446","url":"https:\/\/flcube.com\/?p=15446","name":"National Health Commission's Anti-Corruption Drive Impacts China's Pharmaceutical Sector - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-08-03T05:18:00+00:00","dateModified":"2024-12-03T14:05:05+00:00","description":"An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July has quickly begun to impact the healthcare industry. Unlike previous efforts led by local authorities, this campaign is being driven by central authorities, with the Commission for Discipline Inspection of the Central Committee of the CPC holding a mobilization meeting in conjunction with the launch. Provinces and cities, including Zhejiang and Guangdong, have introduced related policies to correct unhealthy practices in pharmaceutical procurement and sales, as well as medical services.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=15446#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=15446"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=15446#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"National Health Commission&#8217;s Anti-Corruption Drive Impacts China&#8217;s Pharmaceutical Sector"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/15446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15446"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/15446\/revisions"}],"predecessor-version":[{"id":16573,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/15446\/revisions\/16573"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}